Dr. Om Parkash Eye Institute Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 27-12-2024
- Paid Up Capital ₹ 1.28 M
as on 27-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.15 Cr
as on 27-12-2024
- Revenue 56.51%
(FY 2022)
- Profit 181.98%
(FY 2022)
- Ebitda 97.20%
(FY 2022)
- Net Worth 53.56%
(FY 2022)
- Total Assets 41.18%
(FY 2022)
About Dr. Om Parkash Eye Institute
The Corporate was formerly known as Om Parkash Eye Institute Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.28 M.
The company has closed loans amounting to ₹5.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rohit Parkash and Geetanjali Parkash serve as directors at the Company.
- CIN/LLPIN
U85110PB2010PTC033755
- Company No.
033755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2010
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr. Om Parkash Eye Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Parkash  | Director | 29-Apr-2024 | Current |
| Geetanjali Parkash | Director | 30-Mar-2010 | Current |
Financial Performance of Dr. Om Parkash Eye Institute.
Dr. Om Parkash Eye Institute Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.51% increase. The company also saw a substantial improvement in profitability, with a 181.98% increase in profit. The company's net worth Soared by an impressive increase of 53.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Om Parkash Eye Institute?
In 2022, Dr. Om Parkash Eye Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 25 Nov 2021 | ₹2.20 Cr | Satisfied |
Others Creation Date: 30 Sep 2020 | ₹0.75 M | Satisfied |
Others Creation Date: 24 Aug 2017 | ₹2.45 M | Satisfied |
How Many Employees Work at Dr. Om Parkash Eye Institute?
Dr. Om Parkash Eye Institute has a workforce of 226 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Om Parkash Eye Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Om Parkash Eye Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
